Bruce Jackson
Stock Analyst at Benchmark
(1.04)
# 3,832
Out of 5,173 analysts
122
Total ratings
29.2%
Success rate
-19.13%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $8.18 | +71.15% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $104.85 | +38.29% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.85 | +224.18% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.85 | +1,546.48% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $45 → $30 | $5.34 | +461.80% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.67 | +482.01% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.49 | +825.55% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $151.14 | -47.07% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $8.10 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $104.91 | -38.04% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.21 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.77 | +343.13% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.29 | +335.54% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.93 | +221.47% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.02 | +390.20% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $2.25 | +2,566.67% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $340 | $0.89 | +37,973.91% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.81 | +2,869.56% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.18 | +2,712.15% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.16 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.51 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.47 | +32,288.66% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $8.18
Upside: +71.15%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $104.85
Upside: +38.29%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.85
Upside: +224.18%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.85
Upside: +1,546.48%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $45 → $30
Current: $5.34
Upside: +461.80%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.67
Upside: +482.01%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.49
Upside: +825.55%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $151.14
Upside: -47.07%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.10
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $104.91
Upside: -38.04%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.21
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.77
Upside: +343.13%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.29
Upside: +335.54%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.93
Upside: +221.47%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $2.25
Upside: +2,566.67%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $340
Current: $0.89
Upside: +37,973.91%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.81
Upside: +2,869.56%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.18
Upside: +2,712.15%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.16
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $18.51
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.47
Upside: +32,288.66%